{
  "protocolSection": {
    "identificationModule": {
      "nctId": "NCT00310492",
      "orgStudyIdInfo": {
        "id": "SHX0556"
      },
      "organization": {
        "fullName": "ALK-Abelló A/S",
        "class": "INDUSTRY"
      },
      "briefTitle": "Efficacy and Safety Trial of ALK-depot SQ Mites in Subjects With Atopic Dermatitis",
      "officialTitle": "Multicenter, Randomized, Double-blind, Placebo-controlled Parallel Group Study to Demonstrate the Efficacy of a 12-month Subcutaneous Specific Immunotherapy With ALK-depot SQ Milbenmischung in Patients With Atopic Dermatitis and Proven IgE-mediated Sensitization to House Dust Mites"
    },
    "statusModule": {
      "statusVerifiedDate": "2015-12",
      "overallStatus": "COMPLETED",
      "expandedAccessInfo": {
        "hasExpandedAccess": false
      },
      "startDateStruct": {
        "date": "2006-04"
      },
      "primaryCompletionDateStruct": {
        "date": "2009-05",
        "type": "ACTUAL"
      },
      "completionDateStruct": {
        "date": "2009-11",
        "type": "ACTUAL"
      },
      "studyFirstSubmitDate": "2006-04-02",
      "studyFirstSubmitQcDate": "2006-04-02",
      "studyFirstPostDateStruct": {
        "date": "2006-04-04",
        "type": "ESTIMATED"
      },
      "lastUpdateSubmitDate": "2015-12-28",
      "lastUpdatePostDateStruct": {
        "date": "2015-12-29",
        "type": "ESTIMATED"
      }
    },
    "sponsorCollaboratorsModule": {
      "responsibleParty": {
        "type": "SPONSOR"
      },
      "leadSponsor": {
        "name": "ALK-Abelló A/S",
        "class": "INDUSTRY"
      }
    },
    "oversightModule": {
      "oversightHasDmc": false
    },
    "descriptionModule": {
      "briefSummary": "This trial is performed to assess the efficacy and safety of ALK-depot SQ mites for treatment of atopic dermatitis"
    },
    "conditionsModule": {
      "conditions": [
        "Atopic Dermatitis"
      ]
    },
    "designModule": {
      "studyType": "INTERVENTIONAL",
      "phases": [
        "PHASE3"
      ],
      "designInfo": {
        "allocation": "RANDOMIZED",
        "interventionModel": "PARALLEL",
        "primaryPurpose": "TREATMENT",
        "maskingInfo": {
          "masking": "DOUBLE",
          "whoMasked": [
            "PARTICIPANT",
            "INVESTIGATOR"
          ]
        }
      },
      "enrollmentInfo": {
        "count": 154,
        "type": "ACTUAL"
      }
    },
    "armsInterventionsModule": {
      "armGroups": [
        {
          "label": "Subcutaneous immunotherapy",
          "type": "ACTIVE_COMPARATOR",
          "description": "Subcutaneous injections with ALK-depot SQ mites to 100,000 SQ-U",
          "interventionNames": [
            "Biological: subcutaneous immunotherapy"
          ]
        },
        {
          "label": "Subcutaneous injections",
          "type": "PLACEBO_COMPARATOR",
          "description": "placebo injections",
          "interventionNames": [
            "Biological: subcutaneous immunotherapy"
          ]
        }
      ],
      "interventions": [
        {
          "type": "BIOLOGICAL",
          "name": "subcutaneous immunotherapy",
          "description": "Updosing by 16 injections to 100,000 SQ-U",
          "armGroupLabels": [
            "Subcutaneous immunotherapy",
            "Subcutaneous injections"
          ],
          "otherNames": [
            "ALK-depot SQ mites"
          ]
        }
      ]
    },
    "outcomesModule": {
      "primaryOutcomes": [
        {
          "measure": "Changes from baseline in SCORAD and topical medication consumption",
          "description": "Sccore of atopic dermatitis (SCORAD)",
          "timeFrame": "1 year"
        }
      ],
      "secondaryOutcomes": [
        {
          "measure": "Changes from baseline in SCORAD intensity score, EASI score and change in topical medication consumption",
          "description": "Eczema Area Severity Index (EASI)",
          "timeFrame": "1 year"
        }
      ],
      "otherOutcomes": [
        {
          "measure": "SCORAD extent criteria, index, subjective symptoms, IGA score, oral rescue medication, exacerbation of atopic dermatitis, DLQI, treatment expectation questionnaire",
          "description": "Investigator´s Global Assessment (IGA), Dermatology Life Quality Index (DLQI)",
          "timeFrame": "1 year"
        }
      ]
    },
    "eligibilityModule": {
      "eligibilityCriteria": "Inclusion Criteria:\n\n* Positive specific IgE to house dust mites\n* Atopic dermatitis according to Hanifin/Rajka\n* Chronic course of Atopic dermatitis\n* SCORAD larger than 25 points\n\nExclusion Criteria:\n\n* Erythrodermia\n* Syst.treatment with gcs or immunosuppressive agents in the prev.4 weeks\n* History of specific immunotherapy with mites\n* UV radiation\n* Group 4 topical corticosteroids (European classification)",
      "healthyVolunteers": false,
      "sex": "ALL",
      "minimumAge": "18 Years",
      "maximumAge": "55 Years",
      "stdAges": [
        "ADULT"
      ]
    },
    "contactsLocationsModule": {
      "overallOfficials": [
        {
          "name": "Hendrik Wolf, PhD",
          "affiliation": "ALK-SCHERAX Arzneimittel GmbH",
          "role": "STUDY_DIRECTOR"
        },
        {
          "name": "Alexander Kapp, MD, Prof.",
          "affiliation": "Hannover Medical School",
          "role": "PRINCIPAL_INVESTIGATOR"
        }
      ],
      "locations": [
        {
          "facility": "Medizinische Hochschule Hannover, Klinik für Dermatologie und Venerologie",
          "city": "Hanover",
          "zip": "D-30449 Hannover",
          "country": "Germany",
          "geoPoint": {
            "lat": 52.37052,
            "lon": 9.73322
          }
        }
      ]
    }
  },
  "derivedSection": {
    "miscInfoModule": {
      "versionHolder": "2026-02-04"
    },
    "conditionBrowseModule": {
      "meshes": [
        {
          "id": "D003876",
          "term": "Dermatitis, Atopic"
        }
      ],
      "ancestors": [
        {
          "id": "D012873",
          "term": "Skin Diseases, Genetic"
        },
        {
          "id": "D030342",
          "term": "Genetic Diseases, Inborn"
        },
        {
          "id": "D009358",
          "term": "Congenital, Hereditary, and Neonatal Diseases and Abnormalities"
        },
        {
          "id": "D003872",
          "term": "Dermatitis"
        },
        {
          "id": "D012871",
          "term": "Skin Diseases"
        },
        {
          "id": "D017437",
          "term": "Skin and Connective Tissue Diseases"
        },
        {
          "id": "D017443",
          "term": "Skin Diseases, Eczematous"
        },
        {
          "id": "D006969",
          "term": "Hypersensitivity, Immediate"
        },
        {
          "id": "D006967",
          "term": "Hypersensitivity"
        },
        {
          "id": "D007154",
          "term": "Immune System Diseases"
        }
      ]
    }
  },
  "hasResults": false
}